Cargando…
Functional genomics identifies new synergistic therapies for retinoblastoma
Local intravitreal or intra-arterial chemotherapy has improved therapeutic success for the pediatric cancer retinoblastoma (RB), but toxicity remains a major caveat. RB initiates primarily with RB1 loss or, rarely, MYCN amplification, but the critical downstream networks are incompletely understood....
Autores principales: | Aubry, Arthur, Pearson, Joel D., Huang, Katherine, Livne-bar, Izhar, Ahmad, Mohammad, Jagadeesan, Madhavan, Khetan, Vikas, Ketela, Troy, Brown, Kevin R., Yu, Tao, Lu, Suying, Wrana, Jeffrey L., Moffat, Jason, Bremner, Rod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391301/ https://www.ncbi.nlm.nih.gov/pubmed/32572160 http://dx.doi.org/10.1038/s41388-020-1372-7 |
Ejemplares similares
-
Genetic perspective of retinoblastoma: From present to future
por: Jagadeesan, Madhavan, et al.
Publicado: (2016) -
Established and New Mouse Models Reveal E2f1 and Cdk2 Dependency of Retinoblastoma and Expose Strategies to Block Tumor Initiation
por: Sangwan, Monika, et al.
Publicado: (2012) -
Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy
por: Aubry, Arthur, et al.
Publicado: (2020) -
How we manage patients with retinoblastoma
por: Khetan, Vikas
Publicado: (2018) -
Commentary: Periocular topotecan for retinoblastoma
por: Sharma, Minal, et al.
Publicado: (2018)